Longevity Science Private Limited incorporated; 51% subscription at Rs.10 per share proposed
Proposed subsidiary Longevity Science Private Limited incorporated on October 8, 2026.
- Incorporation Date
- Longevity Science Private Limited incorporated on October 8, 2026
- CIN
- U21001HR2026PTC151534
- Proposed Subscription
- 51% - 51,000 shares of Rs.10 each for cash, totalling Rs.5,10,000
Longevity Science Private Limited is now incorporated
Astonea Labs has informed the exchange that the company it had proposed as a subsidiary has been incorporated. The name is Longevity Science Private Limited and it was incorporated on October 8, 2026 under the Companies Act, 2013. The Registrar of Companies has issued the Certificate of Incorporation and allotted the company CIN U21001HR2026PTC151534. This intimation follows the Board's approval of the proposal, which was disclosed earlier on September 9, 2026.
What is proposed
- The company proposes to subscribe to 51% of the initial paid-up equity share capital of Longevity Science Private Limited.
- That 51% comprises 51,000 equity shares of Rs.10 each.
- The subscription is for cash consideration, at Rs.10 per equity share, aggregating to Rs.5,10,000.
- The subscription and allotment are yet to be completed and are subject to completion of the requisite formalities and applicable approvals. Longevity Science Private Limited will become a subsidiary only upon completion of the proposed subscription and allotment.
What the new entity will do
- Line of business: pharmaceuticals, healthcare, nutraceuticals and allied products.
- Presence of the entity: India.
- Turnover for the last three years: not applicable, as the entity is newly incorporated.
Related party and approval details
- Upon completion of the proposed subscription and allotment, Longevity Science Private Limited will become a related party of the company.
- The promoter and promoter group have no direct or indirect interest in Longevity Science Private Limited, except to the extent of their shareholding in the company.
- The proposed subscription is intended to be undertaken on an arm's length basis.
- No specific governmental or regulatory approval is envisaged for the proposed subscription and allotment, other than statutory updates and compliances as may be applicable.
- The indicative time period given is completion at the earliest, subject to the requisite formalities and applicable approvals. The company has said it will make further disclosures as applicable once the subscription and allotment are completed.
How to read this
The update is an update on a step already placed before the exchange: the incorporation has happened, while the investment into the new company is proposed and not yet completed. The proposed cash outlay for the 51% stake is Rs.5,10,000, being 51,000 equity shares at Rs.10 per equity share. The business the new entity is proposed to carry on is pharmaceuticals, healthcare, nutraceuticals and allied products.
More numbers
- Stake proposed to be subscribed in subsidiary51%
- Price per equity share proposedRs.10
- Total proposed cash subscription amountRs.5,10,000
- Equity shares proposed to be subscribed51,000 equity shares
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.